China In-vitro Diagnostic Reagent Industry Report 2017-2021 - Research and Markets
DUBLIN, Apr. 21, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Research Report on China In-vitro Diagnostic Reagent Industry, 2017-2021" report to their offering.
The market size of China in-vitro diagnostic reagents reached about CNY 26 billion (USD 3.9 billion) in 2016, of which the leading three were immune, biochemical and molecular products.
The global in-vitro diagnostic market is mature and the concentration rate is high. Top 5 manufacturers of global in-vitro diagnostic industry are Roche, Siemens, JNJ, Abbott and Beckman with an aggregate market share of over 60% in the globe as monopolies.
The market size of in-vitro diagnostics is closely related to the population base, medical treatment expenses per capita, medical care level and medical technology together with service levels of a country. At present, the demand market of global in-vitro diagnostics is mainly distributed in developed economies such as North America, Europe and Japan.
In China, major consumption demand for in-vitro diagnostic reagents derives from medical testing and blood screening. Medical testing is the major consumer of in-vitro diagnostic reagents including hospital clinical laboratory, physical examination center, independent laboratory and epidemic prevention station. Meanwhile, blood screening is mainly applied in blood collection and supply departments including various blood stations and blood product manufacturers. Presently, hospitals are major demand markets of in-vitro diagnostic reagents in China.
China's population accounts for more than 20% of the world, while the market share of in-vitro diagnostics is less than 10%. In 2016, the annual consumption per capita of China's in-vitro diagnostic products was less than USD 3, while that of developed countries reached USD 25 to USD 30. Therefore, there is a wide increase space for China's in-vitro diagnostic market. It is estimated that from 2017 to 2021, the market scale of China's in-vitro diagnostic market will develop at a growth rate exceeding that of the average global level to about CNY 49 billion with the CAGR of over 10%. Meanwhile, major shares will be occupied by immune and biochemical products, and molecular products will grow with a higher proportion.
Key Topics Covered:
1 Basic Concepts of In-vitro Diagnostic Reagent Industry
1.1 Definition of In-vitro Diagnostic Reagents
1.2 Classification of In-vitro Diagnostic Reagents
1.3 Industry Chain of In-vitro Diagnostic Reagents
1.4 Research Methods of the Report
2 Analysis on Global In-vitro Diagnostic Industry, 2011-2016
2.1 Overview on Global In-vitro Diagnostic Reagent Industry
2.2 Analysis on Major Global Manufacturers of In-vitro Diagnostic Reagents
3 Development Environment of China In-vitro Diagnostic Reagent Industry, 2011-2016
3.1 Economic Environment of In-vitro Diagnostic Reagent Industry
3.2 Policy Environment of In-vitro Diagnostic Reagent Industry
4 Operation Status of China Diagnostic Reagent Industry, 2011-2016
4.1 Development History of China In-vitro Diagnostic Reagent Industry
4.2 Supply Status of China In-vitro Diagnostic Reagent Industry
4.2.1 Major Manufacturers of China In-vitro Diagnostic Reagents
4.2.2 Supply Ability of China In-vitro Diagnostic Reagents
4.3 Market Demand for China In-vitro Diagnostic Reagents, 2011-2016
4.4 Analysis on Import and Export of In-vitro Diagnostic Reagents in China
4.5 Price Trend of Raw Materials of China In-vitro Diagnostic Reagents in China
4.5 Price Trend of In-vitro Diagnostic Reagents in China
5 Analysis on Competition in China In-vitro Diagnostic Reagent Industry, 2011-2016
5.1 Barriers to Entry in China In-vitro Diagnostic Reagent Industry
5.2 Competition Structure of China In-vitro Diagnostic Reagent Industry
6 Analysis on Major Manufacturers of In-vitro Diagnostic Reagents in China, 2013-2016
6.1 Shanghai Kehua Bio-engineering Co., Ltd.
6.2 Shenzhen Mindray Bio-medical Electronics Co., Ltd.
6.3 Sichuan Maccura Biotechnology Co., Ltd.
6.4 Shanghai Fosun Pharmaceutical Co., Ltd.
6.5 DAAN Gene Co., Ltd. of Sun Yat-sen University
6.6 Beijing Leadman Biochemistry Co., Ltd.
6.7 BioSino Bio-technology and Science Inc.
7 Prospect of China In-vitro Diagnostic Reagent Industry, 2017-2021
7.1 Factors Influencing the Development of In-vitro Diagnostic Reagent Industry in China
7.2 Forecast on Supply of China In-vitro Diagnostic Reagent Industry, 2017-2021
7.3 Forecast on Demand of China In-vitro Diagnostic Reagent Industry, 2017-2021
7.4 Forecast on Market Competition of In-vitro Diagnostic Reagent Industry in China
Companies Mentioned
- Abbott Laboratories
- Beckman Coulter
- Beijing Leadman Biochemistry Co., Ltd.
- BioSino Bio-technology and Science Inc.
- DAAN Gene Co., Ltd. of Sun Yat-sen University
- F. Hoffmann-La Roche Ltd
- JNJ
- Shanghai Fosun Pharmaceutical Co., Ltd.
- Shanghai Kehua Bio-engineering Co., Ltd.
- Shenzhen Mindray Bio-medical Electronics Co., Ltd.
- Sichuan Maccura Biotechnology Co., Ltd.
- Siemens AG
For more information about this report visit http://www.researchandmarkets.com/research/hqfjw2/research_report
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article